Ask AI
H.R. 4701

Tick-Borne Disease Research Accountability and Transparency Act of 2014

Tick-Borne Disease Research Accountability and Transparency Act of 2014 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to conduct or support epidemiological, basic, translational, and clinical research regarding Lyme disease and other tick-borne diseases.

Directs the Secretary to establish the Interagency Lyme and Tick-Borne Disease Working Group to review all HHS efforts concerning tick-borne diseases to ensure interagency coordination and examine research priorities. Requires the Working Group to: (1) provide a summary of tick-borne disease research, advances, and scientific viewpoints every two years; (2) make recommendations to HHS regarding tick-borne disease activities; and (3) hold annual public meetings.

Requires HHS to submit a strategic plan for tick-borne disease research within three years of enactment and every five years thereafter that includes: (1) budgetary requirements; (2) benchmarks for improving tick-borne disease diagnosis, treatment, outcomes, and prevention; and (3) a plan to disseminate Working Group summaries and other relevant information on tick-borne disease to health professionals and the public.

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Rep. Gibson, Christopher P. [R-NY-19](R-NY)Sponsor
19 cosponsors12 D7 R
19cosponsors2committees20actions6subjects
  • Referred in SenateSep 10, 2014
  • Engrossed in HouseSep 9, 2014
  • Reported in HouseSep 8, 2014
  • Introduced in HouseMay 21, 2014
  1. IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. FloorH38800

    The title of the measure was amended. Agreed to without objection.

  3. FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  4. FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7344-7345)

  5. Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7344-7345)

  6. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 4701.

  7. FloorH30000

    Considered under suspension of the rules. (consideration: CR H7344-7347)

  8. FloorH30300

    Mr. Burgess moved to suspend the rules and pass the bill, as amended.

  9. CalendarsH12410

    Placed on the Union Calendar, Calendar No. 424.

  10. CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-573.

  11. Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-573.

  12. Committee

    Ordered to be Reported (Amended) by Voice Vote.

  13. Committee

    Committee Consideration and Mark-up Session Held.

  14. Committee

    Committee Consideration and Mark-up Session Held.

  15. Committee

    Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent .

  16. Committee

    Subcommittee Consideration and Mark-up Session Held.

  17. Committee

    Referred to the Subcommittee on Health.

  18. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

  19. IntroReferralIntro-H

    Introduced in House

  20. IntroReferral1000

    Introduced in House

Sep 9, 201436

Tick-Borne Disease Research Accountability and Transparency Act of 2014 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to conduct or support epidemiological, basic, translational, and clinical research regarding Lyme disease and other tick-borne diseases.

Directs the Secretary to establish the Interagency Lyme and Tick-Borne Disease Working Group to review all HHS efforts concerning tick-borne diseases to ensure interagency coordination and examine research priorities. Requires the Working Group to: (1) provide a summary of tick-borne disease research, advances, and scientific viewpoints every two years; (2) make recommendations to HHS regarding tick-borne disease activities; and (3) hold annual public meetings.

Requires HHS to submit a strategic plan for tick-borne disease research within three years of enactment and every five years thereafter that includes: (1) budgetary requirements; (2) benchmarks for improving tick-borne disease diagnosis, treatment, outcomes, and prevention; and (3) a plan to disseminate Working Group summaries and other relevant information on tick-borne disease to health professionals and the public.
Sep 8, 201417

Tick-Borne Disease Research Accountability and Transparency Act of 2014 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to conduct or support epidemiological, basic, translational, and clinical research regarding Lyme disease and other tick-borne diseases.

Directs the Secretary to establish the Interagency Lyme and Tick-Borne Disease Working Group to review all HHS efforts concerning tick-borne diseases to ensure interagency coordination and examine research priorities. Requires the Working Group to: (1) provide a summary of tick-borne disease research, advances, and scientific viewpoints every two years; (2) make recommendations to HHS regarding tick-borne disease activities; and (3) hold annual public meetings.

Requires HHS to submit a strategic plan for tick-borne disease research within three years of enactment and every five years thereafter that includes: (1) budgetary requirements; (2) benchmarks for improving tick-borne disease diagnosis, treatment, outcomes, and prevention; and (3) a plan to disseminate Working Group summaries and other relevant information on tick-borne disease to health professionals and the public.
May 21, 2014

Vector-Borne Disease Research Accountability and Transparency Act of 2014 - Amends the Public Health Service Act to require the Directors of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to: (1) develop scientific frameworks for research on at least two vector-borne diseases that have a high domestic incidence, and (2) convene a working group for each identified disease.

Defines "vector-borne disease" as an infection transmitted to humans or other animals by ticks, mosquitoes, or fleas. Treats tick-borne diseases, including Lyme disease, as a single such disease.

Tick-Borne Disease Research Accountability and Transparency Act of 2014 — Informed